Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study

Alessandro Cozzi‐Lepri(University College London), Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), Lı́dia Ruiz(IrsiCaixa), Adriano Lazzarin(Vita-Salute San Raffaele University), Ole Kirk(University of Copenhagen), Bonaventura Clotet(Universitat de Vic - Universitat Central de Catalunya), Amanda Mocroft(University of Copenhagen), Andrew Phillips(Wake Forest University), Anders Karlsson(Karolinska University Hospital), Alicja Wiercińska‐Drapało(Medical University of Białystok)
AIDS
October 2, 2008
10.1097/qad.0b013e328310e04f
Cited by 43

Related Papers

Industrial enzyme applications
|Current Opinion in Biotechnology|2002|1.5k
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
|JAMA|2016|1.4k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998